Aumolertinib in EGFR-Mutant Resected Stage IB-IIIA NSCLC (AERESA).
Clinical trial NCT06227897 · WITHDRAWN
Trial details
- NCT number
- NCT06227897
- Sponsor
- Sun Yat-sen University
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.